Britain’s health minister said on Monday that the country has secured 5 million doses of Moderna’s experimental COVID-19 vaccine, reports Reuters. The news comes after Moderna announced on Monday from its interim data that its vaccine candidate is 94.5% effective and has no significant safety concerns.
- Moderna expects emergency authorizations of its vaccine candidate after final analysis to be conducted later this month, along with two months of safety follow-up data.
- Moderna’s vaccine has been found to prevent all symptomatic COVID-19 cases.
- Britain’s agreement comes when Moderna’s vaccine candidate has been shown to be stable at refrigerator temperatures for 30 days, higher than the previously estimated seven days.
UK stocks are currently gaining. FTSE 100 is up 1.66%